Biotherm, Inc.

Company Information
Address 5301 Departure Drive
Raleigh, NC, 27604


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Rapid Monitoring of Antithrombin Agents

    Amount: $749,999.00

    A functional assay system for monitoring antithrombin drugs, such as recombinant hirudin andhirudin analogs, in patients will be developed. This assay system will be based on a novel dry reagentparama ...

    SBIRPhase II1996Department of Health and Human Services
  2. Rapid Immunoassay for Acute Myocardial Injury Detection

    Amount: $100,000.00

    Phase I is directed at the development of a rapid and quantitative diagnostic immunoassay for acuteinjury. This immunoassay will utilize a proven dry chemistry test system incorporating a cardiac-spec ...

    SBIRPhase I1995Department of Health and Human Services
  3. Rapid Monitoring of Antithrombin Agents

    Amount: $75,000.00

    N/A

    SBIRPhase I1994Department of Health and Human Services
  4. DRUG CHALLENGE ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $500,000.00

    A TEST SYSTEM FOR RAPID SCREENING OF PATIENTS PRIOR TO INITIATION OF THROMBOLYTIC THERAPY WILL BE DEVELOPED. THIS SYSTEM WILL BE BASED ON A NOVEL DRY REAGENT ASSAY TECHNOLOGY WHICH RECENTLY HAS BEEN A ...

    SBIRPhase II1993Department of Health and Human Services
  5. RAPID FIBRINOGEN ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $500,000.00

    AN ASSAY SYSTEM FOR MONITORING FUNCTIONAL FIBRINOGEN IN PATIENTS UNDERGOING THROMBOLYTIC THERAPY WILL BE DEVELOPED. THIS SYSTEM WILL BE BASED ON A NOVEL DRY REAGENT ASSAY TECHNOLOGY THAT HAS RECENTLY ...

    SBIRPhase II1992Department of Health and Human Services
  6. DRUG CHALLENGE ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $50,000.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  7. RAPID FIBRINOGEN ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $50,000.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  8. PORTABLE SYSTEM FOR CONTROL OF ANTICOAGULANT THERAPY

    Amount: $500,000.00

    BIOTHERM, INC. PROPOSES TO DESIGN AND DEVELOP A PORTABLE SYSTEM, ANALOGOUS TO A HAND-HELD GLUCOSE METER, TO PERMIT RAPID, CONVENIENT BLOOD COAGULATION TESTING ON FRESHLY DRAWNSAMPLES FROM PATIENTS UND ...

    SBIRPhase II1988Department of Health and Human Services
  9. PORTABLE SYSTEM FOR CONTROL OF ANTICOAGULANT THERAPY

    Amount: $50,000.00

    N/A

    SBIRPhase I1987Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government